Showing results (91-100 of 137) with videos related to

Sort By:
Pageof 14
Mutagenesis|January 11, 2020
Expression quantitative trait loci in ABC transporters are associated with survival in 5-FU treated colorectal cancer patientsVeronika Vymetalkova, Fabio Rosa, Simona Susova, et al.
Molecular Carcinogenesis|March 4, 2014
Post-treatment recovery of suboptimal DNA repair capacity and gene expression levels in colorectal cancer patientsJana Slyskova, Francesca Cordero, Barbara Pardini, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 2, 2019
Fusobacterium nucleatum tumor DNA levels are associated with survival in colorectal cancer patientsAndrew T Kunzmann, Marcela Alcântara Proença, Haydee Wt Jordao, et al.
Annals of Medicine|October 13, 2025
Spatial immunoprofiling of retroperitoneal leiomyosarcomas reveals intratumoral heterogeneity in immune cell infiltration, checkpoint molecule expression, and tertiary lymphoid structuresIva Benesova, Jan Balko, Vira Tovazhnianska, et al.
Clinical Genitourinary Cancer|June 27, 2025
Cabozantinib in the First-Line Treatment of Patients With Metastatic Renal Cell Carcinoma, Real-World Data From the Czech Republic and Poland: ICARO-RC ProjectJakub Kucharz, Alexandr Poprach, Bożena Sikora-Kupis, et al.
Targeted Oncology|October 25, 2018
Impact of Delayed Addition of Anti-EGFR Monoclonal Antibodies on the Outcome of First-Line Therapy in Metastatic Colorectal Cancer Patients: a Retrospective Registry-Based AnalysisOndrej Fiala, Veronika Veskrnova, Renata Chloupkova, et al.
Urologic Oncology|January 27, 2019
Tyrosine kinase inhibitors in the first-line treatment for metastatic nonclear cell renal carcinoma: A retrospective analysis of a national databaseAlexandr Poprach, Kristina Rumanova, Radek Lakomý, et al.
Drugs & Aging|August 20, 2016
Efficacy of Sunitinib in Elderly Patients with Metastatic Renal Cell Carcinoma: Data from Real-World Clinical PracticeAlexandr Poprach, Radek Lakomy, Zbynek Bortlicek, et al.
Targeted Oncology|November 13, 2023
Impact of Immunotherapy on Real-World Survival Outcomes in Metastatic Renal Cell CarcinomaAlexandr Poprach, Igor Kiss, Michal Stanik, et al.
European Journal of Cancer (Oxford, England : 1990)|March 22, 2024
A global phase II randomized trial comparing oral taxane ModraDoc006/r to intravenous docetaxel in metastatic castration resistant prostate cancerUlka N Vaishampayan, Marianne Keessen, Robert Dreicer, et al.
Pageof 14